Compare Trimegah Bangun Persada Tbk. (NCKL) vs Brigit Biofarmaka Teknologi Tbk. (OBAT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Trimegah Bangun Persada Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Trimegah Bangun Persada Tbk. trades at Rp925 (market cap 57.42T, 37.91M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp236 (market cap 164.65B, 62.5K 24h volume). The key difference: Trimegah Bangun Persada Tbk. is far larger — about 348.7× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Trimegah Bangun Persada Tbk. is more actively traded (37.91M versus 62.5K). Which is the better fit depends on your goals.
| NCKL | OBAT | |
|---|---|---|
Market Cap | 57.42T | 164.65B |
Volume | 37.91M | 62.5K |
Lot | 379.1K | 625 |
Turnover | 34.83B | 15.03M |
Average Price | 918.76 | 240.55 |
Value | 34.83B | 15.03M |
Indicative Equilibrium Price | 925 | 238 |
Indicative Equilibrium Volume | 10.28K | 100 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Trimegah Bangun Persada Tbk.
PT Trimegah Bangun Persada Tbk. (the Company) was established in Indonesia based on Notarial Deed of Erna Priyono, S.H., No. 03 dated September 6, 2004.
Read more on NCKL →About Brigit Biofarmaka Teknologi Tbk.
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →
